About
Regensight is an Italian med-tech and pharmaceutical company based in Rome, founded in July 2019. The company specializes in developing and marketing theranostic ophthalmic medical devices that aim to improve vision and quality of life. Their innovative platform assists eye surgeons in performing safe and effective operations for major visual disorders, including keratoconus, myopia, and presbyopia. This platform utilizes a controlled photo-polymerization process of corneal tissue proteins through UV-A light, enabling precise and predictive treatments. Regensight holds several patents related to its technology, which has achieved Technology Readiness Level (TRL) 9 for keratoconus treatment, indicating full commercial deployment. The company provides advanced solutions to eye surgeons and ophthalmic clinics, along with remote maintenance and software updates through secure remote access. This connectivity allows for global monitoring and troubleshooting of devices, ensuring high standards of security and compliance with healthcare requirements. Regensight is dedicated to enhancing eye surgery outcomes and patient care through its innovative solutions.
Technologies
Keywords
Company Information
-
Employees 6
-
Founded 2019
Location
Rome, Lazio, Italy
